Sensorion SA (EPA:ALSEN)
France
· Delayed Price · Currency is EUR 0.374
+0.001 (0.27%)
Apr 28, 2026, 5:35 PM CET
Sensorion Revenue
In the year 2025, Sensorion had annual revenue of 5.81M EUR, down -12.61%. Sensorion had revenue of 3.49M in the half year ending December 31, 2025, with 10.91% growth.
Revenue
5.81M
Revenue Growth
-12.61%
P/S Ratio
33.07
Revenue / Employee
92.29K
Employees
63
Market Cap
192.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.81M | -839.00K | -12.61% |
| Dec 31, 2024 | 6.65M | 955.00K | 16.76% |
| Dec 31, 2023 | 5.70M | 764.35K | 15.49% |
| Dec 31, 2022 | 4.93M | 669.94K | 15.71% |
| Dec 31, 2021 | 4.26M | 1.91M | 81.27% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Transgene | 7.21M |
| Cellectis | 67.79M |
| ABIONYX Pharma | 4.10M |
| Innate Pharma | 9.01M |
| MaaT Pharma | 4.52M |
| Valneva SE | 174.66M |
| Genfit | 65.43M |
| Adocia | 3.85M |
Sensorion News
- 2 months ago - Sensorion: CEO Nawal Ouzren To Resign - Nasdaq
- 1 year ago - Sensorion Transcript: Investor Update - Transcripts
- 1 year ago - Sensorion Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025 - Transcripts